Detalles de la búsqueda
1.
IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypes.
Clin Immunol
; 260: 109922, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38320737
2.
Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells.
N Engl J Med
; 385(10): 921-929, 2021 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34469647
3.
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
Blood
; 137(23): 3291-3305, 2021 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657221
4.
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
J Clin Immunol
; 41(7): 1633-1647, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324127
5.
Rebound and overshoot of donor-specific antibodies to human leukocyte antigens (HLA) during desensitization with plasma exchanges in hematopoietic progenitor cell transplantation: A case report.
Transfusion
; 61(6): 1980-1986, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33899963
6.
Immune Reconstitution Inflammatory Syndrome as a Posttransplantation Complication in Primary Immunodeficiency With Disseminated Mycobacterium avium.
Clin Infect Dis
; 70(4): 676-679, 2020 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31190050
7.
Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.
Biol Blood Marrow Transplant
; 26(1): 94-106, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31493539
8.
Successful Matched Related Bone Marrow Transplantation in a Patient with Autosomal Dominant Interferon Gamma Receptor 1 Deficiency.
J Clin Immunol
; 40(7): 1045-1047, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32696284
9.
Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study.
Clin Transplant
; 34(12): e14121, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33048385
10.
Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1666-1673, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30986499
11.
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1859-1868, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31132455
12.
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.
Biol Blood Marrow Transplant
; 25(3): 577-586, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30342913
13.
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Blood
; 129(10): 1389-1393, 2017 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28049637
14.
The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases.
Blood
; 127(16): 2007-17, 2016 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26744460
15.
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
J Clin Immunol
; 42(7): 1580-1581, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35499644
16.
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.
Blood
; 125(19): 3024-31, 2015 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25814532
17.
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
Haematologica
; 102(2): 391-400, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27846611
18.
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.
Blood
; 124(25): 3817-27, 2014 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25316679
19.
Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors.
Biol Blood Marrow Transplant
; 21(12): 2115-2122, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26183076
20.
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Blood
; 121(18): 3547-53, 2013 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23386127